Buprenorphine versus full agonist opioids for acute postoperative pain management: an infographic
Open Access
- 9 January 2025
- journal article
- research article
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 51 (5) , 594-595
Abstract
Opioids continue to play a role in postoperative pain management and continue to result in predictable harm to patients including persistent use and overdose.1 Buprenorphine, a partial agonist opioid, has an almost 60-year track record of efficacy in acute pain management. However, in contemporary practice, it is rarely used for this purpose and is better known as an essential medicine for opioid use disorder. In this systematic review and meta-analysis of randomized controlled trials, the authors aimed to broaden the understanding of buprenorphine’s efficacy versus opioids as a class in the treatment of acute postoperative pain in adults. Inclusion criteria were met for 58 studies.Keywords
This publication has 1 reference indexed in Scilit:
- Incidence of Postoperative Opioid Overdose and New Diagnosis of Opioid Use Disorder Among US VeteransThe American Journal on Addictions, 2020